# Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

> **NCT03214939** · EARLY_PHASE1 · UNKNOWN · sponsor: **Research Institute of Fundamental and Clinical Immunology** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Immunotherapy based on dendritic cells

## Key facts

- **NCT ID:** NCT03214939
- **Lead sponsor:** Research Institute of Fundamental and Clinical Immunology
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09-27
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03214939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03214939, "Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03214939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*